alzheon, Author at Alzheon | Preserving Future Memories - Page 5 of 20

About alzheon

This author has not yet filled in any details.
So far alzheon has created 200 blog entries.

18 Apr, 2023

Alzheon to Present Baseline Imaging Characteristics from Ongoing APOLLOE4 Phase 3 Trial of Oral Tablet ALZ-801 (Valiltramiprosate) and Results of Phase 2 Biomarker Study at American Academy of Neurology Conference in Boston

alzheon2024-08-12T09:50:32-04:00April 18th, 2023|

22 Mar, 2023

Alzheon to Present Biomarker, Brain Preservation and Clinical Effects of Oral Tablet ALZ-801 (Valiltramiprosate) at Upcoming AD/PD 2023 Conference in Gothenburg, Sweden

alzheon2024-08-12T09:51:50-04:00March 22nd, 2023|

20 Mar, 2023

The New Era of Life Sciences

alzheon2024-08-02T09:47:38-04:00March 20th, 2023|

12 Mar, 2023

Why lecanemab’s success spells the revival of small-molecule Alzheimer’s treatments

alzheon2024-05-15T16:38:27-04:00March 12th, 2023|

21 Feb, 2023

Newsweek Investment Report: Interview with Dr. Martin Tolar, President & CEO of Alzheon, Inc.

alzheon2023-04-16T12:18:58-04:00February 21st, 2023|

17 Feb, 2023

‘It’s night and day’: Biogen’s new Alzheimer’s drug may spur more investment in fighting the disease

alzheon2024-08-02T08:55:07-04:00February 17th, 2023|

15 Feb, 2023

I interview Dr. Martin Tolar, Founder, CEO and President of Alzheon on the Phase 3 trial going on right now

alzheon2023-02-16T12:37:20-05:00February 15th, 2023|

20 Jan, 2023

Biotech and Business Development Leader Wendy Nelson on Living With the APOE4 Gene

alzheon2023-01-20T11:31:56-05:00January 20th, 2023|

6 Dec, 2022

Alzheon Announces Early Completion of Enrollment of APOLLOE4 Phase 3 Clinical Trial Evaluating Oral ALZ-801 (Valiltramiprosate) in APOE4/4 Homozygotes with Early Alzheimer’s Disease

alzheon2024-08-26T10:56:30-04:00December 6th, 2022|

22 Nov, 2022

Alzheon to Present Industry-Leading Biomarker, Brain Preservation, and Clinical Effects with Oral ALZ-801 (Valiltramiprosate) at 15th Annual Clinical Trials in Alzheimer’s Disease Conference

alzheon2024-08-12T09:59:56-04:00November 22nd, 2022|